Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Depression. Taking part may give some people access to Vagus Nerve Stimulation, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Clinical High Risk, Psychosis, Remission, or Conversion to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Anticholinergic Deprescription with Healthy Controls for people with Schizophrenia or schizoaffective disorder. Participants receive Anticholinergic Deprescription or Healthy Controls and complete study visits and assessments.
This study is comparing Cromoglycate with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Cromoglycate or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia, schizoaffective disorder, or Control Subjects to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at demonstrate safety of acute and chronic network guided stimulation for treatment-refractory schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing BXCL501 80 Micrograms with placebo for people with psychosis or bipolarity. Participants receive BXCL501 80 Micrograms or placebo and complete study visits and assessments.
This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at take place at four outpatient clinics serving adults with serious mental illness for people with Schizophrenia or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive Sham Stimulation + Task instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether a digital support tool can help people with Schizophrenia, Schizophreniform Disorder, or schizoaffective disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is comparing Lumateperone with placebo for people with Schizophrenia or Schizo Affective Disorder. Participants receive Lumateperone or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1 or Schizo Affective Disorder. Participants take part in a digital support tool and complete follow-up assessments.
This study is looking at whether Closed-loop auditory stimulation can help people with Schizophrenia. Participants take part in Closed-loop auditory stimulation and complete follow-up assessments.
This observational study is following people with Schizophrenia, bipolarity, or Autism Spectrum Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether questionnaires and follow-up can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing SPG302 with placebo for people with Schizophrenia. Participants receive SPG302 or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia or Schizo Affective Disorder to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at identify novel markers of psychosis using electroencephalography (EEG) for people with Schizophrenia Disorders, bipolarity, or Schizo Affective Disorder. Taking part may give some people access to EEG measure of visual processing, but direct benefit is not guaranteed.
This study is comparing LB-102 with placebo for people with Bipolarity I. Participants receive LB-102 or placebo and complete study visits and assessments.
This observational study is following people with anxiety to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at evaluate the feasibility and acceptability of Positive Affect Treatment (PAT) in a Spanish-speaking population for people with Anhedonia, Depression in, or Anxiety. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is comparing Tocilizumab with Healthy Control for people with depression. Participants receive Tocilizumab or Healthy Control and complete study visits and assessments.
This study is looking at care and outcomes for people with Chronic Low Back Pain. Taking part may give some people access to MBM, but direct benefit is not guaranteed.